Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE

Standard Dose
EQ 200MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 217685 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE HYCLATE Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/VIAL Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2025-03-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 217685 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE HYCLATE Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/VIAL Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2025-03-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.